PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center, New York, NY, USA. ag3786@cumc.columbia.edu.\', \'Cardiovascular Research Foundation, New York, NY, USA. ag3786@cumc.columbia.edu.\', \'Yale Center for Outcomes Research and Evaluation, New Haven, CT, USA. ag3786@cumc.columbia.edu.\', \'NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center, New York, NY, USA.\', \'Cardiovascular Research Foundation, New York, NY, USA.\', \'Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Yale Center for Outcomes Research and Evaluation, New Haven, CT, USA.\', \'The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center, New York, NY, USA. eyw2003@cumc.columbia.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-021-21553-1
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33637713
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all